CN Patent

CN100463668C — 可逆性热凝胶化水性药物组合物

Assigned to Shandong Academy of Pharmaceutical Sciences · Expires 2009-02-25 · 17y expired

What this patent protects

可用于药理性治疗或诊断的眼科用，鼻腔用及其他体腔用和皮肤科用的可逆性热凝胶化水性药物组合物。该组合物由不同作用的有效量药物、一定浓度的甲基纤维素、多价酸盐以及pH调节剂等组成，具有给药或涂布前为流动性强的液体，给药或涂布后在局部的体温下迅速凝胶化的特征。

USPTO Abstract

可用于药理性治疗或诊断的眼科用，鼻腔用及其他体腔用和皮肤科用的可逆性热凝胶化水性药物组合物。该组合物由不同作用的有效量药物、一定浓度的甲基纤维素、多价酸盐以及pH调节剂等组成，具有给药或涂布前为流动性强的液体，给药或涂布后在局部的体温下迅速凝胶化的特征。

Drugs covered by this patent

Patent Metadata

Patent number
CN100463668C
Jurisdiction
CN
Classification
—
Expires
2009-02-25
Drug substance claim
No
Drug product claim
No
Assignee
Shandong Academy of Pharmaceutical Sciences
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.